Ohio Public Employees Retirement System (OPERS)
TCRR

Ohio Public Employees Retirement System (OPERS)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,863
Closed -$34K – 2005
2022
Q3 		$34K Buy
+18,863
New +$54.7K ﹤0.01% 1935

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s TCRR Position: Q4 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2022, closing a stake of 18,863 shares — an estimated $34K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in TCRR in Q3 2022 and held it in 1 quarter. The position peaked at $34K in Q3 2022. 63 funds tracked by Wall St. Rank hold TCRR as of Q4 2022.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 18,863 TCR2 Therapeutics Inc. Common Stock shares in Q4 2022, an estimated $34K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in TCR2 Therapeutics Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Ohio Public Employees Retirement System (OPERS)'s TCR2 Therapeutics Inc. Common Stock position peaked at $34K in Q3 2022.
  • 63 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2022, filed 15 Feb 2023.